The Importance of the Learning Curve and Surveillance of Surgical Performance in Peritoneal Surface Malignancy Programs

Surgical Oncology Clinics of North America

Volumn 21, Issue 4, 2012, Pages 559-576

  Kusamura, Shigeki ^a   Baratti, Dario ^a   Hutanu, Ionut ^b   Rossi, Piero ^c   Deraco, Marcello ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Learning curve

Indexed keywords

ADULT; CANCER SURGERY; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HEALTH PROGRAM; HUMAN; HYPERTHERMIC THERAPY; LEARNING CURVE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORBIDITY; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PERITONEUM PSEUDOMYXOMA; PROFESSIONAL COMPETENCE; REVIEW; RISK ASSESSMENT; SURGICAL RISK;

ANALYSIS OF VARIANCE; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; HUMANS; INFUSIONS, PARENTERAL; LEARNING CURVE; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RISK; TEACHING;

EID: 84866780938     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2012.07.011     Document Type: Review

References (40)

1. Elias D., Gilly F., Quenet F., et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010, 36:456-462. Association Française de Chirurgie.
2. Baratti D., Kusamura S., Nonaka D., et al. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg 2009, 249:243-249.
3. Yan T.D., Deraco M., Baratti D., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 2009, 27:6237-6242.
4. Deraco M., Baratti D., Cabras A.D., et al. Experience with peritoneal mesothelioma at the Milan National Cancer Institute. World J Gastrointest Oncol 2010, 2:76-84.
5. Cao C., Yan T.D., Black D., et al. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2009, 16:2152-2165. Review.
6. Esquivel J., Elias D., Baratti D., et al. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 2008, 98:263-267. Review.
7. Kusamura S., Younan R., Baratti D., et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006, 106:1144-1153.
8. Deraco M., Baratti D., Kusamura S. Morbidity and quality of life following cytoreduction and HIPEC. Cancer Treat Res 2007, 134:403-418. Review.
9. Yan T.D., Links M., Fransi S., et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol 2007, 14:2270-2280.
10. Cavaliere F., Valle M., De Rosa B., et al. Suppl Tumori 2005, 4(3):S119-S121. [in Italian].
11. Smeenk R.M., Verwaal V.J., Zoetmulder F.A. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 2007, 94:1408-1414.
12. Mohamed F., Moran B.J. Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J 2009, 15:196-199. Review.
13. Wald A. Sequential tests in industrial statistics. Ann Math Stat 1945, 6:117-186.
14. Matheny M.E., Ohno-Machado L., Resnic F.S. Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology. Am Heart J 2008, 155(1):114-120.
15. Chen T.T., Chung K.P., Hu F.C., et al. The use of statistical process control (risk-adjusted CUSUM, risk-adjusted RSPRT and CRAM with prediction limits) for monitoring the outcomes of out-of-hospital cardiac arrest patients rescued by the EMS system. J Eval Clin Pract 2011, 17(1):71-77.
16. Grigg O.A., Farewell V.T., Spiegelhalter D.J. Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts. Stat Methods Med Res 2003, 12(2):147-170.
17. Steiner S.H., Cook R.J., Farewell V.T. Risk-adjusted monitoring of binary surgical outcomes. Med Decis Making 2001, 21:163-169.
18. Rogers C.A., Reeves B.C., Caputo M., et al. Control chart methods for monitoring cardiac surgical performance and their interpretation. J Thorac Cardiovasc Surg 2004, 128(6):811-819.
19. Kusamura S., Baratti D., Deraco M. Multidimensional analysis of learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Annals of Surgery 2011, 255(2):348-356.
20. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 1995, 221:29-42.
21. Deraco M., Baratti D., Kusamura S., et al. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol 2009, 100:321-328.
22. Jacquet P., Sugarbaker P.H. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 1996, 15:49-58.
23. Fujimoto S., Takahashi M., Kobayashi K., et al. Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case. Surg Today 1993, 23:1094-1098.
24. Baratti D., Kusamura S., Nonaka D., et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008, 15:526-534.
25. Rossi C.R., Foletto M., Mocellin S., et al. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer 2002, 94:492-499.
26. Younan R., Kusamura S., Baratti D., et al. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 2008, 98:253-257. Review.
27. Younan R., Kusamura S., Baratti D., et al. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005, 12:910-918.
28. Kusamura S., Baratti D., Younan R., et al. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol 2007, 14:2550-2558.
29. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
30. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
31. Lemeshow S., Hosmer D.W. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982, 115:92-106.
32. Chua T., Yan T.D., Saxena A., et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg 2009, 249:900-907.
33. Glehen O., Gilly F.N., Boutitie F., et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 2010, 116:5608-5618. French Surgical Association.
34. Park I.J., Choi G.S., Lim K.H., et al. Multidimensional analysis of the learning curve for laparoscopic resection in rectal cancer. J Gastrointest Surg 2009, 13:275-281.
35. Son G.M., Kim J.G., Lee J.C., et al. Multidimensional analysis of the learning curve for laparoscopic rectal cancer surgery. J Laparoendosc Adv Surg Tech A 2010, 20(7):609-617.
36. Schlachta C.M., Mamazza J., Seshadri P.A., et al. Defining a learning curve for laparoscopic colorectal resections. Dis Colon Rectum 2001, 44:217-222.
37. Axelrod D.A., Guidinger M.K., Metzger R.A., et al. Transplant center quality assessment using a continuously updatable, risk-adjusted technique (CUSUM). Am J Transplant 2006, 6(2):313-323.
38. Chua T.C., Moran B.J., Sugarbaker P.H., et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012, 30(20):2449-2456.
39. González Bayón L., Sugarbaker P.H., Gonzalez Moreno S., et al. Initiation of a program in peritoneal surface malignancy. Surg Oncol Clin N Am 2003, 12(3):741-753. Review.
40. Moran B.J. Establishment of a peritoneal malignancy treatment centre in the United Kingdom. Eur J Surg Oncol 2006, 32(6):614-618.